-
Executive Summary
-
Research Scope & Segmentation
- Research Objectives
- Limitations & Assumptions
- Market Scope & Segmentation
- Currency & Pricing Considered
-
Market Opportunity Assessment
- Emerging Regions / Countries
- Emerging Companies
- Emerging Applications / End Use
-
Market Trends
- Drivers
- Market Warning Factors
- Macro Economic Indicators
- Geopolitical Impact
- Technology Factors
-
Market Assessment
- Porters Five Forces Analysis
- Value Chain Analysis
-
Preclinical CRO Market Size Analysis
- Introduction
- Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
-
Bioanalysis and DMPK studies
-
In vitro ADME
-
In-vivo PK
-
Toxicology Testing
-
GLP
-
Non-GLP
-
Compound Management
-
Process R&D
-
Custom Synthesis
-
Others
-
Chemistry
-
Medicinal Chemistry
-
Computation Chemistry
-
Safety Pharmacology
-
Others
- Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
-
Patient-Derived Organoid (PDO) Model
-
Patient-Derived Xenograft Model
- Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
Oncology
-
Neurology
-
Cardiology
-
Infectious Diseases
-
Metabolic Disorders
-
Others
- Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
-
Pharmaceutical and Biotechnological Companies
-
Government and Academic Institutes
-
Medical Device Companies
-
Others
-
North America Preclinical CRO Market Size Analysis
- Introduction
- Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
-
Bioanalysis and DMPK studies
-
In vitro ADME
-
In-vivo PK
-
Toxicology Testing
-
GLP
-
Non-GLP
-
Compound Management
-
Process R&D
-
Custom Synthesis
-
Others
-
Chemistry
-
Medicinal Chemistry
-
Computation Chemistry
-
Safety Pharmacology
-
Others
- Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
-
Patient-Derived Organoid (PDO) Model
-
Patient-Derived Xenograft Model
- Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
Oncology
-
Neurology
-
Cardiology
-
Infectious Diseases
-
Metabolic Disorders
-
Others
- Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
-
Pharmaceutical and Biotechnological Companies
-
Government and Academic Institutes
-
Medical Device Companies
-
Others
- U.S. Preclinical CRO Market Size Analysis
- Introduction
- Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
-
Bioanalysis and DMPK studies
-
In vitro ADME
-
In-vivo PK
-
Toxicology Testing
-
GLP
-
Non-GLP
-
Compound Management
-
Process R&D
-
Custom Synthesis
-
Others
-
Chemistry
-
Medicinal Chemistry
-
Computation Chemistry
-
Safety Pharmacology
-
Others
- Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
-
Patient-Derived Organoid (PDO) Model
-
Patient-Derived Xenograft Model
- Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
Oncology
-
Neurology
-
Cardiology
-
Infectious Diseases
-
Metabolic Disorders
-
Others
- Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
-
Pharmaceutical and Biotechnological Companies
-
Government and Academic Institutes
-
Medical Device Companies
-
Others
- Canada Preclinical CRO Market Size Analysis
- Introduction
- Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
-
Bioanalysis and DMPK studies
-
In vitro ADME
-
In-vivo PK
-
Toxicology Testing
-
GLP
-
Non-GLP
-
Compound Management
-
Process R&D
-
Custom Synthesis
-
Others
-
Chemistry
-
Medicinal Chemistry
-
Computation Chemistry
-
Safety Pharmacology
-
Others
- Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
-
Patient-Derived Organoid (PDO) Model
-
Patient-Derived Xenograft Model
- Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
Oncology
-
Neurology
-
Cardiology
-
Infectious Diseases
-
Metabolic Disorders
-
Others
- Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
-
Pharmaceutical and Biotechnological Companies
-
Government and Academic Institutes
-
Medical Device Companies
-
Others
-
Europe Preclinical CRO Market Size Analysis
-
APAC Preclinical CRO Market Size Analysis
-
Middle East and Africa Preclinical CRO Market Size Analysis
-
LATAM Preclinical CRO Market Size Analysis
- Competitive Landscape
- Preclinical CRO Market Share By Players
- M&A Agreements & Collaboration Analysis
- Tier Structure Analysis
- Recent Developments
- Market Players Assessment
- Charles River Laboratories International, Inc.
- Overview
- Business Information
- Revenue
- ASP
- SWOT Analysis
- Recent Developments
- Covance Inc.
- ICON plc
- Medpace, Inc.
- WuXi AppTec
- Envigo
- PRA Health Sciences
- Syngene International Limited
- Eurofins Scientific
- Parexel International Corporation
- SGS SA
- MPI Research
- Crown Bioscience, Inc.
- Toxikon Corporation
- Pharmaron
- Research Methodology
- Research Data
- Secondary Data
- Major Secondary Sources
- Key Data from Secondary Sources
- Primary Data
- Key Data from Primary Sources
- Breakdown of Primaries
- Secondary And Primary Research
- Key Industry Insights
- Market Size Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Projection
- Research Assumptions
- Assumptions
- Limitations
- Risk Assessment
- Appendix
- Discussion Guide
- Customization Options
- Related Reports
- Disclaimer